Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types

Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types

Reynold Panettieri Jr,1 Njira Lugogo,2 Jonathan Corren,3 Christopher S Ambrose4 1Rutgers Institute for Translational Medicine and Science, Rutgers University, New Brunswick, NJ, USA; 2Michigan Medicine Asthma Program, University of Michigan, Ann Arbor, MI, USA; 3Departments of Medicine and Pediatric...

Full description

Bibliographic Details
Main Authors: Panettieri R Jr, Lugogo N, Corren J, Ambrose CS
Format: Article
Language:English
Published: Dove Medical Press 2024-03-01
Series:Journal of Asthma and Allergy
Subjects:
exacerbations
eosinophilic
allergic
type 2
oral corticosteroid-dependent
airway hyperresponsiveness
Online Access:https://www.dovepress.com/tezepelumab-for-severe-asthma-one-drug-targeting-multiple-disease-path-peer-reviewed-fulltext-article-JAA

Internet

https://www.dovepress.com/tezepelumab-for-severe-asthma-one-drug-targeting-multiple-disease-path-peer-reviewed-fulltext-article-JAA

Similar Items